214 related articles for article (PubMed ID: 18046432)
1. Randomized study of traditional versus aggressive systolic blood pressure control (Cardio-Sis): rationale, design and characteristics of the study population.
Cardio-Sis Study Group
J Hum Hypertens; 2008 Apr; 22(4):243-51. PubMed ID: 18046432
[TBL] [Abstract][Full Text] [Related]
2. Tight versus standard blood pressure control in patients with hypertension with and without cardiovascular disease.
Reboldi G; Angeli F; de Simone G; Staessen JA; Verdecchia P;
Hypertension; 2014 Mar; 63(3):475-82. PubMed ID: 24343119
[TBL] [Abstract][Full Text] [Related]
3. Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial.
Ogihara T; Saruta T; Rakugi H; Fujimoto A; Ueshima K; Yasuno S; Oba K; Takeda K; Higaki J; Nakao K;
Hypertens Res; 2009 Apr; 32(4):248-54. PubMed ID: 19347033
[TBL] [Abstract][Full Text] [Related]
4. Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?
Verdecchia P; Angeli F; Gattobigio R; Guerrieri M; Benemio G; Porcellati C
J Hum Hypertens; 2004 Dec; 18 Suppl 2():S23-8. PubMed ID: 15592569
[TBL] [Abstract][Full Text] [Related]
5. EXCEED: Exforge-intensive control of hypertension to evaluate efficacy in diastolic dysfunction: study rationale, design, and participant characteristics.
Hassanein A; Desai A; Verma A; Oparil S; Izzo J; Rocha R; Hilkert R; Seifu Y; Pitt B; Solomon S
Ther Adv Cardiovasc Dis; 2009 Dec; 3(6):429-39. PubMed ID: 19638366
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
[TBL] [Abstract][Full Text] [Related]
7. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial.
Verdecchia P; Staessen JA; Angeli F; de Simone G; Achilli A; Ganau A; Mureddu G; Pede S; Maggioni AP; Lucci D; Reboldi G;
Lancet; 2009 Aug; 374(9689):525-33. PubMed ID: 19683638
[TBL] [Abstract][Full Text] [Related]
8. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure variability as well as blood pressure level is important for left ventricular hypertrophy and brachial-ankle pulse wave velocity in hypertensives.
Ozawa M; Tamura K; Okano Y; Matsushita K; Ikeya Y; Masuda S; Wakui H; Dejima T; Shigenaga A; Azuma K; Ishigami T; Toya Y; Ishikawa T; Umemura S
Clin Exp Hypertens; 2009 Nov; 31(8):669-79. PubMed ID: 20001459
[TBL] [Abstract][Full Text] [Related]
10. Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study.
Olsen MH; Wachtell K; Ibsen H; Lindholm LH; Dahlöf B; Devereux RB; Kjeldsen SE; Oikarinen L; Okin PM;
J Hypertens; 2006 Apr; 24(4):775-81. PubMed ID: 16531808
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of serial electrocardiographic voltage and repolarization changes in essential hypertension: the HEART Survey study.
Verdecchia P; Reboldi G; Angeli F; Avanzini F; de Simone G; Pede S; Perticone F; Schillaci G; Vanuzzo D; Maggioni AP;
Am J Hypertens; 2007 Sep; 20(9):997-1004. PubMed ID: 17765142
[TBL] [Abstract][Full Text] [Related]
12. Trends in hypertension control and left ventricular hypertrophy over three years.
Cuspidi C; Michey I; Meani S; Severgnini B; Fusi V; Salerno M; Valerio C; Magrini F; Zanchetti A
Ital Heart J; 2002 Sep; 3(9):514-9. PubMed ID: 12407847
[TBL] [Abstract][Full Text] [Related]
13. Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients.
Okin PM; Hille DA; Larstorp AC; Wachtell K; Kjeldsen SE; Dahlöf B; Devereux RB
Hypertension; 2015 Aug; 66(2):368-73. PubMed ID: 26056336
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of left ventricular hypertrophy as assessed by electrocardiogram in treated hypertensive persons in general practice.
van den Hoogen JP; van Kruijsdijk MC; van Ree JW; Mokkink HG; Thien T; van Weel C
J Hum Hypertens; 1993 Oct; 7(5):473-7. PubMed ID: 8263888
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
Ruilope LM; Schmieder RE
Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
[TBL] [Abstract][Full Text] [Related]
16. Further evidence for low-dose combinations in patients with left ventricular hypertrophy.
Dahlöf B
J Hum Hypertens; 2005 Jun; 19 Suppl 1():S9-14. PubMed ID: 16075032
[TBL] [Abstract][Full Text] [Related]
17. Electrocardiographic abnormalities and home blood pressure in treated elderly hypertensive patients: Japan home versus office blood pressure measurement evaluation in the elderly (J-HOME-Elderly) study.
Shibamiya T; Obara T; Ohkubo T; Shinki T; Ishikura K; Yoshida M; Satoh M; Hashimoto T; Hara A; Metoki H; Inoue R; Asayama K; Kikuya M; Imai Y;
Hypertens Res; 2010 Jul; 33(7):670-7. PubMed ID: 20431591
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).
Van der Niepen P; Woestenburg A; Brié H; Vancayzeele S; MacDonald K; Denhaerynck K; Lee C; Hermans C; Abraham I
Ann Pharmacother; 2009 May; 43(5):849-61. PubMed ID: 19351876
[TBL] [Abstract][Full Text] [Related]
19. From treatment to organ damage; a 5-year follow-up study of ambulatory blood pressure in essential hypertension. Diversity between development of left ventricular hypertrophy and urinary albumin excretion.
Stenehjem AE; Bjørnerheim R; Os I
Blood Press; 2007; 16(2):87-94. PubMed ID: 17612906
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of left ventricular hypertrophy in Finnish primary health care hypertensive patients.
Kumpusalo E; Lappi J; Miettinen H; Takala J
J Hum Hypertens; 2001 Apr; 15(4):255-8. PubMed ID: 11319673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
